[(1-methylcyclopropyl)methyl]amine hydrochloride, 95.0%, 1g

N-(1-Adamantyl)acrylamide>95.0%(GC)(T)500mg

3-AMINOPENTANEDIOIC ACID HCL, 95%, 250mg

tert-Butyl 8-hydroxy-3,4-dihydroquinoline-1(2H)-carboxylate, 95.0%, 5g

5-(5-bromopyridin-3-yl)-1,3,4-oxadiazol-2-amine, 95.0%, 500mg

1-(2-Fluoroethyl)piperidin-4-amine dihydrochloride, 95.0%, 100mg

tert-Butyl 4-(3-hydroxyphenyl)piperazine-1-carboxylate, 95.0%, 2.5g

iScope IS.1152-PLPHi Biocular with Plan phase IOS objectives and Rackless cross table (infinity)

2-(4-Fluorophenyl)imidazo[1,2-a]pyridine, 95.0%, 250mg

5-Chloro-1-methylpyrazin-2(1H)-one, 98%, 250mg

4,6-Dichloro-2-phenylpyrimidine, 95.0%, 500g

2,6-Di(pyridin-4-yl)pyrimidin-4-ol, 95.0%, 1g

2-Ethyl-3-hydroxy-6-methylpyridine Succinate>98.0%(T)1g